The difference in Ki67 expression between primary and metastatic lesions has been studied in a number of cancers including breast, colon, gastrointestinal stromal (GIST) and bladder cancer, with contrasting results. The gene discussed is MKI67; the disease is gastrointestinal stromal tumor.